Impact of anxiety and depression on the prognosis of copd exacerbations
Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly. To establish the prevalence of depression and anxiety in patien...
Saved in:
Published in | BMC pulmonary medicine Vol. 22; no. 1; p. 169 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
29.04.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly.
To establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis.
Prospective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study.
288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90).
The prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). |
---|---|
AbstractList | Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly.
To establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis.
Prospective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study.
288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90).
The prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). Background Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly. Aim To establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis. Methods Prospective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study. Results 288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90). Conclusion The prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly. To establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis. 288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90). The prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). Abstract Background Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly. Aim To establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis. Methods Prospective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study. Results 288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90). Conclusion The prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). BACKGROUNDFrequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly. AIMTo establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis. METHODSProspective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study. RESULTS288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90). CONCLUSIONThe prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). Background Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly. Aim To establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis. Methods Prospective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study. Results 288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90). Conclusion The prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). Keywords: COPD, Anxiety, Depression, Prognosis Abstract Background Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on COPD prognosis. However, they are underdiagnosed and rarely treated properly. Aim To establish the prevalence of depression and anxiety in patients admitted for Acute Exacerbation of COPD (AECOPD) and determine their influence on COPD prognosis. Methods Prospective observational study conducted from October 1, 2016 to October 1, 2018 at the following centers in Galicia, Spain: Salnés County Hospital, Arquitecto Marcide, and Clinic Hospital Complex of Santiago de Compostela. Patients admitted for AECOPD who agreed to participate and completed the anxiety and depression scale (HADS) were included in the study. Results 288 patients (46.8%) were included, mean age was 73.7 years (SD 10.9), 84.7% were male. 67.7% patients were diagnosed with probable depression, and depression was established in 41.7%; anxiety was probable in 68.2% and established in 35.4%. 60.4% of all patients showed symptoms of both anxiety and depression. Multivariate analysis relates established depression with a higher risk of late readmission (OR 2.06, 95% CI 1.28; 3.31) and a lower risk of mortality at 18 months (OR 0.57, 95% CI 0.37; 0.90). Conclusion The prevalence of anxiety and depression in COPD patients is high. Depression seems to be an independent factor for AECOPD, so early detection and a multidisciplinary approach could improve the prognosis of both entities. The study was approved by the Ethical Committee of Galicia (code 2016/460). |
ArticleNumber | 169 |
Audience | Academic |
Author | Calvo-Álvarez, Uxío Salgado, Francisco-Javier Camba-Matos, Sandra García-Sanz, María-Teresa González-Pérez, Miguel-Angel Doval-Oubiña, Liliana González-Barcala, Francisco-Javier Carreira, José-Martín Peleteiro-Pedraza, Lorena Martínez-Gestoso, Sandra Penela-Penela, Pedro Vilas-Iglesias, Andrés |
Author_xml | – sequence: 1 givenname: Sandra surname: Martínez-Gestoso fullname: Martínez-Gestoso, Sandra organization: Emergencies Department, Salnés Couny Hospital, Vilagarcía de Arousa, Spain – sequence: 2 givenname: María-Teresa surname: García-Sanz fullname: García-Sanz, María-Teresa email: maytegsanz@gmail.com organization: Translational Research in Airway Diseases Group (TRIAD)-Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. maytegsanz@gmail.com – sequence: 3 givenname: José-Martín surname: Carreira fullname: Carreira, José-Martín organization: Radiology Department, University of Santiago de Compostela, Santiago de Compostela, Spain – sequence: 4 givenname: Francisco-Javier surname: Salgado fullname: Salgado, Francisco-Javier organization: Spanish Biomedical Research Networking Centre-CIBERES, Madrid, Spain – sequence: 5 givenname: Uxío surname: Calvo-Álvarez fullname: Calvo-Álvarez, Uxío organization: Respiratory Medicine, Arquitecto Marcide Hospital, Ferrol, Spain – sequence: 6 givenname: Liliana surname: Doval-Oubiña fullname: Doval-Oubiña, Liliana organization: Emergencies Department, Salnés Couny Hospital, Vilagarcía de Arousa, Spain – sequence: 7 givenname: Sandra surname: Camba-Matos fullname: Camba-Matos, Sandra organization: Emergencies Department, Salnés Couny Hospital, Vilagarcía de Arousa, Spain – sequence: 8 givenname: Lorena surname: Peleteiro-Pedraza fullname: Peleteiro-Pedraza, Lorena organization: University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain – sequence: 9 givenname: Miguel-Angel surname: González-Pérez fullname: González-Pérez, Miguel-Angel organization: Primary Care, CS Valle-Inclán, Ourense, Spain – sequence: 10 givenname: Pedro surname: Penela-Penela fullname: Penela-Penela, Pedro organization: Respiratory Medicine, HM Hospital, Santiago de Compostela, Spain – sequence: 11 givenname: Andrés surname: Vilas-Iglesias fullname: Vilas-Iglesias, Andrés organization: Respiratory Medicine, HM Hospital, Santiago de Compostela, Spain – sequence: 12 givenname: Francisco-Javier surname: González-Barcala fullname: González-Barcala, Francisco-Javier organization: Department of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35488330$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl1rFDEYhYNUbLv6B7yQAW-8mZrvZG6EUrQuFLzR65DJvNlmmU3GZFa6_95st9ZuaRJIePOckw_OOTqJKQJC7wm-IETLz4VQ3eEWU9pi0jHe7l6hM8IVaSmX8uTJ-hSdl7LGmCgt2Bt0ygTXmjF8hq6Xm8m6uUm-sfEuwLyr89AMMGUoJaTY1DHfQjPltIqphLJHXZqGBu6sg9zbuVLlLXrt7Vjg3cO8QL--ff159b29-XG9vLq8aZ2QbG4FSE41OGGZJEwMjlMrQNtOsU56gZUduMc9cdI7yxnnmHW4d72qIiaZZwu0PPgOya7NlMPG5p1JNpj7QsorY_Mc3AhGOKE0kbKDQXKpfEcF4VbqWrWe1-ss0JeD17TtNzA4iHO245Hp8U4Mt2aV_pgOC8q1qgafHgxy-r2FMptNKA7G0UZI22KoFJpS2VFS0Y_P0HXa5li_qlL7phVW_6mVrQ8I0ad6rtubmkuFKdZUdLhSFy9QtQ-wCa5mxIdaPxLQg8DlVEoG__hGgs0-SuYQJVOjZO6jZHZV9OHp7zxK_mWH_QWCPcO6 |
CitedBy_id | crossref_primary_10_1080_15412555_2024_2361669 crossref_primary_10_3390_arm91020011 crossref_primary_10_3233_THC_230665 crossref_primary_10_1097_MD_0000000000036702 crossref_primary_10_1159_000530277 crossref_primary_10_1016_j_rmed_2023_107451 crossref_primary_10_1080_17476348_2023_2282022 crossref_primary_10_3389_fpsyg_2023_1134718 crossref_primary_10_3389_fpsyt_2022_996451 crossref_primary_10_1186_s12890_024_02889_y crossref_primary_10_1016_j_jad_2024_02_022 crossref_primary_10_1186_s12890_022_02060_5 crossref_primary_10_1016_j_arbres_2022_05_009 crossref_primary_10_1183_16000617_0170_2022 crossref_primary_10_1515_biol_2022_0693 crossref_primary_10_1016_j_rmed_2024_107558 crossref_primary_10_1186_s12890_022_01999_9 crossref_primary_10_3390_healthcare11081175 crossref_primary_10_3390_jcm11216337 crossref_primary_10_3346_jkms_2024_39_e164 crossref_primary_10_3389_fphar_2023_1307651 crossref_primary_10_2147_COPD_S455397 |
Cites_doi | 10.1016/j.arbres.2019.12.025 10.1016/j.arbres.2019.06.021 10.1007/s00408-016-9862-7 10.1007/s11845-016-1431-9 10.1164/rccm.201105-0939PP 10.1016/j.arbres.2018.09.007 10.1016/j.jpsychores.2019.03.004 10.1186/s40248-016-0041-8 10.1016/j.jpain.2019.08.003 10.1186/s12931-019-1154-3 10.1016/j.genhosppsych.2011.03.009 10.1016/j.rmed.2020.106089 10.1016/j.jad.2007.07.002 10.21037/jtd.2017.03.34 10.1007/s00406-014-0566-9 10.1186/1471-2458-13-976 10.2147/COPD.S237545 10.2147/COPD.S157165 10.1016/j.arbres.2021.03.026 10.2147/COPD.S123994 10.1016/j.arbres.2019.08.005 10.1016/j.arbr.2018.11.008 10.1016/S0163-8343(03)00043-4 10.1080/15412555.2019.1679102 10.1513/AnnalsATS.201509-618AS 10.1016/j.rmed.2020.106018 10.3109/15412555.2014.898026 10.1016/j.arbres.2008.06.001 10.1186/1471-2466-11-49 10.1002/ejhf.1112 10.1016/j.arbr.2021.05.023 10.1183/16000617.0026-2017 10.4187/respcare.01862 10.1080/13607863.2016.1186153 10.2147/COPD.S179109 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12890-022-01934-y |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health Medical collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ : Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Statistics |
EISSN | 1471-2466 |
EndPage | 169 |
ExternalDocumentID | oai_doaj_org_article_5c5781669ed6467f92514a68578af456 A702082590 10_1186_s12890_022_01934_y 35488330 |
Genre | Journal Article Observational Study |
GeographicLocations | Spain |
GeographicLocations_xml | – name: Spain |
GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EBD EBLON EBS ECM EIF EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX CITATION ABVAZ AFGXO AFNRJ 7TO 7XB 8FK AZQEC DWQXO H94 K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c563t-5e6428ec5a36135dc42a5e8a97396f507ad4f0b1c6fca43440390bcb728e363f3 |
IEDL.DBID | RPM |
ISSN | 1471-2466 |
IngestDate | Tue Oct 22 15:08:45 EDT 2024 Tue Sep 17 21:12:44 EDT 2024 Fri Oct 25 11:44:20 EDT 2024 Thu Oct 10 18:54:24 EDT 2024 Thu Feb 22 23:48:10 EST 2024 Tue Nov 12 22:34:24 EST 2024 Thu Sep 12 17:18:05 EDT 2024 Sat Sep 28 08:18:38 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Depression Anxiety Prognosis COPD |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-5e6428ec5a36135dc42a5e8a97396f507ad4f0b1c6fca43440390bcb728e363f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052487/ |
PMID | 35488330 |
PQID | 2666668707 |
PQPubID | 44785 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5c5781669ed6467f92514a68578af456 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9052487 proquest_miscellaneous_2658226921 proquest_journals_2666668707 gale_infotracmisc_A702082590 gale_infotracacademiconefile_A702082590 crossref_primary_10_1186_s12890_022_01934_y pubmed_primary_35488330 |
PublicationCentury | 2000 |
PublicationDate | 2022-04-29 |
PublicationDateYYYYMMDD | 2022-04-29 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC pulmonary medicine |
PublicationTitleAlternate | BMC Pulm Med |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 35637477 - BMC Pulm Med. 2022 May 30;22(1):213 1934_CR1 MT García-Sanz (1934_CR4) 2017; 9 C Laurin (1934_CR30) 2012; 185 C Rabade-Castedo (1934_CR11) 2019; 55 MW Zhang (1934_CR24) 2011; 33 MJ Herrero (1934_CR19) 2003; 25 J De Miguel Díez (1934_CR2) 2020; 56 I Alfageme (1934_CR9) 2019; 55 N Zareifopoulos (1934_CR36) 2019; 16 AS Iyer (1934_CR28) 2016; 13 EM Giusti (1934_CR37) 2020; 21 M Zysman (1934_CR32) 2019; 20 MT García-Sanz (1934_CR3) 2021 C Martínez Rivera (1934_CR26) 2016; 194 PA Coventry (1934_CR29) 2011; 11 GA Maters (1934_CR16) 2014; 4 L Lecheler (1934_CR13) 2017; 26 J Ancochea (1934_CR38) 2009; 45 D Deng (1934_CR12) 2020; 15 1934_CR8 MT García-Sanz (1934_CR18) 2017; 186 JJ Soler-Cataluña (1934_CR5) 2021; 57 A Borrás-Santos (1934_CR10) 2019; 55 J-H Lee (1934_CR22) 2018; 13 JL Izquierdo (1934_CR6) 2021; 57 H Badr (1934_CR23) 2017; 21 D Schoepf (1934_CR15) 2015; 265 SAA Vikjord (1934_CR14) 2020 DR Ouellette (1934_CR34) 2017; 12 EH Ouaalaya (1934_CR31) 2020; 169 C Zilz (1934_CR33) 2016; 11 RM Arabyat (1934_CR17) 2019; 20 A Blakemore (1934_CR7) 2019; 14 I Sokoreli (1934_CR20) 2018; 20 MA Bemmer (1934_CR35) 2008; 106 TY Tsai (1934_CR21) 2013; 13 T Phan (1934_CR27) 2019; 120 TG Willgoss (1934_CR25) 2013; 58 |
References_xml | – volume: 57 start-page: 94 year: 2021 ident: 1934_CR6 publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2019.12.025 contributor: fullname: JL Izquierdo – volume: 55 start-page: 557 year: 2019 ident: 1934_CR11 publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2019.06.021 contributor: fullname: C Rabade-Castedo – volume: 20 start-page: 1 year: 2019 ident: 1934_CR17 publication-title: Ann Behav Med contributor: fullname: RM Arabyat – volume: 194 start-page: 335 year: 2016 ident: 1934_CR26 publication-title: Lung doi: 10.1007/s00408-016-9862-7 contributor: fullname: C Martínez Rivera – volume: 57 start-page: 247 year: 2021 ident: 1934_CR5 publication-title: Ach Bronconeumol contributor: fullname: JJ Soler-Cataluña – volume: 186 start-page: 477 year: 2017 ident: 1934_CR18 publication-title: Ir J Med Sci doi: 10.1007/s11845-016-1431-9 contributor: fullname: MT García-Sanz – volume: 185 start-page: 918 year: 2012 ident: 1934_CR30 publication-title: Am J Respir Care Med doi: 10.1164/rccm.201105-0939PP contributor: fullname: C Laurin – volume: 55 start-page: 312 year: 2019 ident: 1934_CR10 publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2018.09.007 contributor: fullname: A Borrás-Santos – volume: 120 start-page: 60 year: 2019 ident: 1934_CR27 publication-title: J Psychosom Res doi: 10.1016/j.jpsychores.2019.03.004 contributor: fullname: T Phan – volume: 11 start-page: 3 year: 2016 ident: 1934_CR33 publication-title: Multidiscip Respir Med doi: 10.1186/s40248-016-0041-8 contributor: fullname: C Zilz – volume: 21 start-page: 375 year: 2020 ident: 1934_CR37 publication-title: J Pain doi: 10.1016/j.jpain.2019.08.003 contributor: fullname: EM Giusti – volume: 20 start-page: 191 year: 2019 ident: 1934_CR32 publication-title: Respir Res doi: 10.1186/s12931-019-1154-3 contributor: fullname: M Zysman – volume: 33 start-page: 217 issue: 3 year: 2011 ident: 1934_CR24 publication-title: Gen Hosp Psychiatry doi: 10.1016/j.genhosppsych.2011.03.009 contributor: fullname: MW Zhang – year: 2020 ident: 1934_CR14 publication-title: Respir Med doi: 10.1016/j.rmed.2020.106089 contributor: fullname: SAA Vikjord – volume: 106 start-page: 249 year: 2008 ident: 1934_CR35 publication-title: J Affect Disord doi: 10.1016/j.jad.2007.07.002 contributor: fullname: MA Bemmer – volume: 9 start-page: 636 issue: 3 year: 2017 ident: 1934_CR4 publication-title: J Thorac Dis doi: 10.21037/jtd.2017.03.34 contributor: fullname: MT García-Sanz – volume: 265 start-page: 387 year: 2015 ident: 1934_CR15 publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-014-0566-9 contributor: fullname: D Schoepf – volume: 13 start-page: 976 year: 2013 ident: 1934_CR21 publication-title: BMC Public Health doi: 10.1186/1471-2458-13-976 contributor: fullname: TY Tsai – volume: 15 start-page: 249 year: 2020 ident: 1934_CR12 publication-title: Int J Chron Obstruct Pulm Dis doi: 10.2147/COPD.S237545 contributor: fullname: D Deng – volume: 13 start-page: 1583 year: 2018 ident: 1934_CR22 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S157165 contributor: fullname: J-H Lee – ident: 1934_CR1 doi: 10.1016/j.arbres.2021.03.026 – volume: 12 start-page: 639 year: 2017 ident: 1934_CR34 publication-title: Int J COPD doi: 10.2147/COPD.S123994 contributor: fullname: DR Ouellette – volume: 56 start-page: 351 issue: 6 year: 2020 ident: 1934_CR2 publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2019.08.005 contributor: fullname: J De Miguel Díez – volume: 55 start-page: 38 year: 2019 ident: 1934_CR9 publication-title: Arch Bronconeumol (Engl Ed) doi: 10.1016/j.arbr.2018.11.008 contributor: fullname: I Alfageme – volume: 25 start-page: 277 year: 2003 ident: 1934_CR19 publication-title: Gen Hosp Psychiatry doi: 10.1016/S0163-8343(03)00043-4 contributor: fullname: MJ Herrero – volume: 16 start-page: 406 year: 2019 ident: 1934_CR36 publication-title: COPD J Chron Obstruct Pulm Dis doi: 10.1080/15412555.2019.1679102 contributor: fullname: N Zareifopoulos – volume: 13 start-page: 197 year: 2016 ident: 1934_CR28 publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.201509-618AS contributor: fullname: AS Iyer – volume: 169 start-page: 106018 year: 2020 ident: 1934_CR31 publication-title: Resp Med doi: 10.1016/j.rmed.2020.106018 contributor: fullname: EH Ouaalaya – volume: 4 start-page: 468 year: 2014 ident: 1934_CR16 publication-title: COPD J Chron Obstruct Pulm Dis doi: 10.3109/15412555.2014.898026 contributor: fullname: GA Maters – volume: 45 start-page: 41 issue: 1 year: 2009 ident: 1934_CR38 publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2008.06.001 contributor: fullname: J Ancochea – volume: 11 start-page: 49 year: 2011 ident: 1934_CR29 publication-title: BMC Pulm Med doi: 10.1186/1471-2466-11-49 contributor: fullname: PA Coventry – ident: 1934_CR8 – volume: 20 start-page: 689 year: 2018 ident: 1934_CR20 publication-title: Eur J Heart Fail doi: 10.1002/ejhf.1112 contributor: fullname: I Sokoreli – year: 2021 ident: 1934_CR3 publication-title: Arch Bronconeumol doi: 10.1016/j.arbr.2021.05.023 contributor: fullname: MT García-Sanz – volume: 26 start-page: 170026 year: 2017 ident: 1934_CR13 publication-title: Eur Respir Rev doi: 10.1183/16000617.0026-2017 contributor: fullname: L Lecheler – volume: 58 start-page: 858 issue: 5 year: 2013 ident: 1934_CR25 publication-title: Respir Care doi: 10.4187/respcare.01862 contributor: fullname: TG Willgoss – volume: 21 start-page: 975 issue: 9 year: 2017 ident: 1934_CR23 publication-title: Aging Ment Health doi: 10.1080/13607863.2016.1186153 contributor: fullname: H Badr – volume: 14 start-page: 1343 year: 2019 ident: 1934_CR7 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S179109 contributor: fullname: A Blakemore |
SSID | ssj0017853 |
Score | 2.5083113 |
Snippet | Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an impact on... Abstract Background Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem... Background Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an... BACKGROUNDFrequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem to have an... Abstract Background Frequent and highly prevalent as comorbidities in Chronic Obstructive Pulmonary Disease (COPD) patients, both depression and anxiety seem... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 169 |
SubjectTerms | Aged Anxiety Anxiety - epidemiology Chronic illnesses Chronic obstructive pulmonary disease Comorbidity Complications and side effects COPD Depression Depression - epidemiology Depression, Mental Dyspnea Female Hospitals Humans Lung diseases Lung diseases, Obstructive Male Medical prognosis Mental depression Mortality Multivariate analysis Obstructive lung disease Patients Population Prognosis Pulmonary Disease, Chronic Obstructive - complications Pulmonary Disease, Chronic Obstructive - epidemiology Pulmonology Quality of life Statistics |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5KDqGX0iR9OI_iQKGHImJbD0vHJCRNAu2pgdyEJEs0FztkN5D8-8zI3mVND73UGAyWbORvNJoZa_QJ4KvviGZNaKYwOGGiTYnpoAXjog21Nh2ahMz2-Utd3YqbO3m3sdUX5YSN9MAjcCcyYJ-qlTKxU6jUyaBBFk5pvOsSWv88-lZmFUxN8wctWqHVEhmtThY1zacxylxHl4YL9jIzQ5mt_-8xecMozRMmNyzQ5Xt4N7mO5enY5B14E_td2P45TY7vwY_rvOKxHFLp-mfKxcRrV65zXfsST_T3SsrJ6ofF_YKqhuGhK-OzC4jv-PfuA9xeXvw-v2LTPgksSMWXTEYKImKQjqNxll0QjZNRO4NiUAkdPteJVPk6qBSc4EJU3FQ--BYf4oon_hG2-qGPn6EMpjKtD7x2nqi-vG5SxOHQJOWj7qQr4PsKNvsw0mHYHEZoZUeQLYJsM8j2pYAzQnZdk6is8w0UsJ0EbP8l4AK-kVwsKRyCH9y0bgAbTNRV9rSlfUYxiqsKOJzVREUJ8-KVZO2kqAuL_gkeOGi1BRyvi-lJSj7r4_BEdSS6Uco0dQGfxo6w_iSOEZ_mHF_ezrrI7JvnJf39n0zjbSrZYLi4_z9AOoC3Te7dgjXmELaWj0_xCL2lpf-SFeMVyq8N2A priority: 102 providerName: Directory of Open Access Journals – databaseName: Health Medical collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1ba9YwNOgE8UXmdd2mVBB8kLC2uTR5GlOcU9AnB99bSHPRvbSf6zfY_v3OSfN1K4KlUMilJOecnEtycg4h7zuPYda4ohKME8rbGKlyilPGW1cr7UEkpGifP-XZOf--Equ84TZmt8otT0yM2g8O98iPQJDAA9TVHq__UswahaerOYXGQ_KobiqJLl3taja4MPE8216UUfJorPFUjaL_Oig2jNObhTBKMfv_5cz3RNPSbfKeHDrdJU-zAlmeTBh_Rh6E_jl5_CMfkb8gX7-le4_lEEvbX6NHJnx9OXu89iW8oPWV6JnVD-PFiE3dsPZluLYOoDzt4b0k56dffn0-ozlbAnVCsg0VAU2J4IRlIKKFd7yxIiirARkygtpnPY9VVzsZneWM84rpqnNdC52YZJG9Ijv90Ic9Ujpd6bZzrLYdBvzqVBMDMEUdZReUF7YgH7dgM-spKIZJxoSSZgKyASCbBGRzU5BPCNm5JQa0TgXD5W-T14cRDlhHLaUOXgLvjhr0Lm6lglIbQckryAfEi8FlB8B3Nt8egAFjACtz0mK2UbDlqoIcLlrCcnHL6i1mTV6uo7kjroK8m6uxJ7qg9WG4wjYClCmpm7ogrydCmKfEwO5TjMHP2wWJLOa8rOkv_qRg3roSDRiN-_8f1gF50iS65bTRh2Rnc3kV3oA2tOneJpK_BdlUBuw priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_OE-ReRM-v6ikVBB8k2jYfTR5ETvE8BX1y4d5CmiZ6IO25uwe7_70zabte8R4sC4UmXTaT-fjNZvILwIumJZo1oZnC5ISJOkamvRaMi9qX2rQYEhLb5zd1uhBfzuTZHkzHHY0CXF2b2tF5Uovlr9eb39t3aPBvk8Fr9WZV0moZo7p0BCxcsO0NuFkJzNSplE_8XVWodWKlLNEhs0ooNW2iufY7ZoEq8fn_67WvhK15SeWVGHVyB26P4DI_HrThLuyF7hBufR2Xzw_hgKDlwMx8Dz59Thsk8z7mrttQ6Sbe23xXGtvl-EF4mFMJV9evzlfU1fcXbR42zuN0DH_23YfFycfvH07ZeKwC81LxNZOBco7gpeMYy2XrReVk0M7grKmI-NC1IhZN6VX0TnAhCm6Kxjc1vsQVj_wB7Hd9Fx5B7k1h6sbz0jXEDNboKgb0niaqJuhWugxeTTK0FwN7hk1Zh1Z2kLhFidskcbvN4D2JedeTmK_Tg375w46GZKVHH1MqZUKr0MlHgwBNOKXxqYuIBjN4SZNkSWNwJrwbtxngDyamK3tc07GkmPQVGRzNeqJd-XnzNM12UkuLcAYv9HF1Bs93zfQm1ap1ob-kPhJRlzJVmcHDQSt2Q-KYIGpUzAzqmb7Mxjxv6c5_JtZvU8gKs8vH_z2-J3BQJX0WrDJHsL9eXoaniKDWzbNkFn8AWB0UgQ priority: 102 providerName: Scholars Portal |
Title | Impact of anxiety and depression on the prognosis of copd exacerbations |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35488330 https://www.proquest.com/docview/2666668707 https://search.proquest.com/docview/2658226921 https://pubmed.ncbi.nlm.nih.gov/PMC9052487 https://doaj.org/article/5c5781669ed6467f92514a68578af456 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFD60HZS-jN3ntQseDPYw1NjWxdJjU9p1g5RSVgh7EbIsbYHVDk0K7b_vkWKHmL0tBBssCeyjc_mO9ekY4HNVhzJrTBKByQlhpfdEWskIZaXNpaoxJMRqn5fi4ob9mPHZDvB-L0wk7dtqftz8vT1u5n8it3Jxa8c9T2x8NT1VGS8QaI93YRcVtE_Ru6WDEgNQvztGivEyD0tpJJDWEc1QRh4PYJ8iTpc0MJ-3glGs2f-vZ94KTUPa5FYcOn8BzzsAmZ6sb_Ql7LjmFexPuyXy1_Dte9z3mLY-Nc1DYGTiuU43jNcmxT-ivjQws5p2OV-GrrZd1Kl7MBalvH6H9wZuzs9-nl6Q7msJxHJBV4S7kEo4yw3FEM1rywrDnTQKJ0N4hH2mZj6rciu8NYwyllGVVbYqcRAV1NO3sNe0jXsPqVWZKitLc1OFgl-VLLxDp6i8qJysuUngay82vVgXxdAxmZBCr-WtUd46yls_JjAJkt30DAWt44X27rfuplVzi64jF0K5WqDv9gpxFzNC4lXjEeQl8CXMiw5mh8K3pts9gDccCljpkzJ8bRRzuSyBo0FPNBc7bO5nVnfmutSIUvCHrqtM4NOmOYwMFLTGtfehD0cwJVSRJ_BurQibR-r1KYFyoCKDZx62oG7HYt6dLn_475GHcFBE7WakUEewt7q7dx8RKK2qEZrHrBzBs8nZ5dX1KL5uwOOUSTxeT36NouE8AZlmFTA |
link.rule.ids | 230,315,730,783,787,867,888,2109,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS90wFA-bwrYXcV-um9s6GOxhBNvmo8nT0KG7bnoZQ8G3kKaJ-tLe2Svof-85bW61DFYKhSYpzcn5TE5-IeRzVSPMGldUQnBCeRkCVU5xynjpcqVrMAk92udczk75zzNxFifcuphWudKJvaKuW4dz5DtgSOAC7iq_Lf5SPDUKV1fjERqPyTpCVUHwtb63P__9Z1xHKMEarbbKKLnT5biuRjGDHVwbxuntxBz1qP3_6uYHxmmaOPnAEh1sko3oQqa7w5g_J49884I8OY6L5C_Jj8N-52PahtQ2N5iTCc86HXNemxRu8PtSzM1q2u6yw6quXdSpv7EO6DzM4r0ipwf7J99nNJ6XQJ2QbEmFx2DCO2EZGGlRO15Y4ZXVMBwygONnax6yKncyOMsZ5xnTWeWqEhoxyQJ7TdaatvFvSOp0psvKsdxWCPlVqSJ4UIs6yMqrWtiEfF2RzSwGWAzThxNKmoHIBohseiKb24TsIWXHmghp3b9or85NlBAjHCiPXErtawnaO2jwvLiVCt7aAG5eQr7guBgUPCC-s3H_APwwQliZ3RLPG4VoLkvI9qQmCIybFq9G1kSB7cw9eyXk01iMLTEJrfHtNdYR4E5JXeQJ2RoYYewSg8hPMQYfLycsMunztKS5vOjhvHUmCggb3_7_tz6Sp7OT4yNzdDj_9Y48K3oe5rTQ22RteXXt34NvtKw-RAG4A9gyC0I |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7aFJZcSt91m7YuFHoojh96WDqmabdJ24QcGshNSLKULjT2kt1A8u87ku1lTW9dDAuWBPZoHt9Yn0YAH0wTyqxRkXFMTjJae58JK2hGaG1LIRsMCbHa5yk_OqffL9jF1lFfkbRvzWK__XO13y5-R27l8srmI08sPzs5lAWrEGjny8bn9-EB2mzBx0R9WECoMQyNe2QEz1dlWFDLAnUdMQ2h2d0uzAiidUEC_3krJMXK_f_6560ANSVPbkWj-SN4OMDI9KB_3Mdwz7VPYHYyLJQ_hW_Hcfdj2vlUt7eBl4n_TbrhvbYpXoj90sDParvVYhW62m7ZpO5WW5R1_yXvGZzPv_46PMqGMxMyyzhZZ8yFhMJZpgkGatZYWmnmhJY4Jdwj-NMN9YUpLfdWU0JpQWRhrKlxEOHEk-ew03atewmplYWsjSWlNqHslxGVd-gapefGiYbpBD6NYlPLvjSGiimF4KqXt0J5qyhvdZfA5yDZTc9Q1jre6K4v1TC5ill0ICXn0jUcPbiXiL6o5gLvao9QL4GPYV5UMD4UvtXDHgJ84FDGSh3U4cxRzOiKBPYmPdFo7LR5nFk1GO1KIVbBHzqwOoH3m-YwMhDRWtfdhD4MIRWXVZnAi14RNq806lMC9URFJu88bUENjyW9B41-9d8j38Hs7Mtc_Tw-_fEadquo6DSr5B7srK9v3BtETmvzNtrIX7cIFDo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+anxiety+and+depression+on+the+prognosis+of+copd+exacerbations&rft.jtitle=BMC+pulmonary+medicine&rft.au=Sandra%2C+Mart%C3%ADnez-Gestoso&rft.au=Mar%C3%ADa-Teresa%2C+Garc%C3%ADa-Sanz&rft.au=Jos%C3%A9-Mart%C3%ADn%2C+Carreira&rft.au=Francisco-Javier%2C+Salgado&rft.date=2022-04-29&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2466&rft.eissn=1471-2466&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12890-022-01934-y&rft.externalDocID=A702082590 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon |